Navigation Links
Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™
Date:8/31/2011

arallel treatment groupRouteTopicalFrequencySingle application Dose Levels0.37% w/v or 0.74% w/vNumber of Subjects132Subject Selection Criteria

  • 2 years of age or older
  • Good health
  • Has an active head lice infestation as determined by an experienced evaluator

  • Primary End Points

  • Proportion of all subjects who are lice free at all follow-up visits through the Day 14 visit

  • Secondary End Points

  • Safety and tolerability of Ha44 Gel
  • Proportion of index subjects who are lice free at all follow-up visits through the Day 14 visit
  • Proportion of all subjects who are lice free at each follow-up study visit (Day 1, 7, 14)
  • To evaluate the pharmacokinetics of Ha44 Gel in a subset of children 2-12 years of age and adults ≥ 18 years of age

  • Trial Location2 sites in USAExpected Duration of the TrialThe trial is expected to in completed in 9 monthsCommercial PartnersNoneSponsorHatchtech Pty LtdAbout HatchtechHatchtech Pty Ltd is a venture-backed specialty pharmaceutical product company that is developing technology for the control of invertebrate pests. The company's investors include, GBS Venture Partners, Queensland Biotechnology Fund, Uniseed, University of Melbourne Endowment Trust, Westscheme and OneVentures Innovation Fund. The OneVentures Innovation Fund is supported by the Australian Government through the IIF program. The IIF is an Australian Government venture capital initiative that has supported Hatchtech

    The company's lead product is DeOvo™, a class leading head lice control agent that aims to overcome the frustrating, costly and inconvenient cycles of re-treatment experienced currently by children and their parents.

    Hatchtech
    '/>"/>

    SOURCE Hatchtech Pty Ltd
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
    5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
    7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
    8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
    9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
    10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
    11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... , October 22, 2014 ... Disposable Gloves Market (Product type, Form, End user, Application ... Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, ... disposable gloves market. Based on key trends tracked, it ... valued at $7.9 billion by 2020, registering a CAGR ...
    (Date:10/22/2014)... Pa. , Oct. 22, 2014  With ... their animal health medications, a Global Pharmaceutical and ... Antares serialization technology and turnkey solution to protect ... - http://photos.prnewswire.com/prnh/20141021/153438 Photo ... product that was serialized and aggregated by the ...
    (Date:10/22/2014)... , Oct. 21, 2014   BioNano Genomics ... latest genomics research centers to purchase an ... the National Cancer Institute (NCI), NIH Intramural Sequencing ... Before Irys, obtaining a comprehensive view of a ... sequencing (NGS) does not deliver the scalability or ...
    Breaking Medicine Technology:Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Xyntek and Antares Serialization Solution Protects Pets Too! 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3
    ... In the USA, each state is responsible for its Women ... the purchase of supplies. A state bid notification for breastpumps ... unusual feature that needs further attention. The bid,s breastpump requirement ... of the women. The state felt that it was acceptable ...
    ... Reportlinker.com announces that a new market research ... Reportlinker Adds Chugai Pharmaceutical Co. ... http://www.reportlinker.com/p0155101/Reportlinker-Adds-Chugai-Pharmaceutical-Co-Ltd-PharmaVitae-Profile.html , Introduction , ... performance for Chugai in the prescription pharmaceutical ...
    Cached Medicine Technology:Do Women Have a Right to a Breastpump That Works? Asks Hygeia 2Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 2Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 3Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 4Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 5Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 6Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 7
    (Date:10/22/2014)... Shriners Hospitals for Children® and UK HealthCare ... location of Shriners Hospitals for Children - Lexington from ... University of Kentucky Albert B. Chandler Hospital. The new ... and operated by Shriners Hospitals for Children, and designed ... their families well into the future. , “The quality ...
    (Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment ... Institutes for Research (AIR) finds that three out of four ... but 42 percent say they are not likely or only ... for coverage. , The AIR survey found wide gaps in ... calculate correctly how much they owe for a routine doctor’s ...
    (Date:10/22/2014)... (PRWEB) October 22, 2014 Healthcare ... completing their continuing education at home or on-the-go ... access to 20 brand new, premium Seminar-on-Demand CE ... catalog of over 2,000 hours of ... customize their educational experience. With such a diverse ...
    (Date:10/22/2014)... CA (PRWEB) October 22, 2014 Lintelus, ... Cormier, Sr. Vice President of Sales, will be speaking ... upcoming Meetings Technology Expo on October 28, at the ... be hosting a booth as well as a Tech ... Lintelus Meeting can create a more engaging event experience. ...
    (Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... and length may be showing a genetic propensity for obesity ... genes have been linked to increased body fat, but the ... lean muscle, the researchers said. At 1 year, kids ... 2 and 3, however, these genes were linked to excessive ...
    Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2
    ... SANTA MONICA, Calif., May 6 Tune in to ... Nancy Shonka Padberg every Thursday at Noon PDT and ... http://www.modavox.com/voiceamerica/vshow.aspx?sid=1535 . May 7 show ... Monica Surfaro Spigelman, and CEO Downtown Tucson Partnership and ...
    ... Can Honor Mom, Receive Miles with DonationsFORT WORTH, Texas, ... launches its 2009 Miles for the Cure(R) fundraising campaign, ... dollar they contribute to Susan G. Komen for the ... the fight against breast cancer by simply visiting ...
    ... to live in for springtime sufferers, , , WEDNESDAY, May ... challenging place to live for people with spring allergies, ... 2009 list of top 100 Spring Allergy Capitals. ... impact that key environmental and medical factors have on ...
    ... Offers Tips for Building Daily Hand Washing Routines NEW ... hand washing is one of the most important steps ... unavoidable and often linger on common household items -- ... spread of germs by building daily hand washing routines ...
    ... conference focused on promoting physical activity on college ... on connecting health care providers and the public ... infiltrating college campuses nationwide. The American College of ... On Campus," a program component to address and ...
    ... HILLS, Calif. and PHILADELPHIA, May 6 ... on the emergency room physician market, has ... which includes both payment and clearinghouse solutions. ... increased pressure to collect from payers and patients, ...
    Cached Medicine News:Health News:Best Boomer Towns Website and Talk Radio Show Highlight Retirement Communities 2Health News:American Airlines Launches 2009 'Miles for the Cure' Campaign to Benefit Susan G. Komen for the Cure 2Health News:American Airlines Launches 2009 'Miles for the Cure' Campaign to Benefit Susan G. Komen for the Cure 3Health News:American Airlines Launches 2009 'Miles for the Cure' Campaign to Benefit Susan G. Komen for the Cure 4Health News:Inspire Your Children To Become 'Germ-Fighters' 2Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 2Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 3Health News:Physicians' Choice Leverages InstaMed's Integrated Platform for Healthcare Payment & Clearinghouse Solutions 2Health News:Physicians' Choice Leverages InstaMed's Integrated Platform for Healthcare Payment & Clearinghouse Solutions 3
    Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y...
    The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
    Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
    The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
    Medicine Products: